Investigators Probe Whether Vaccines Triggered Adverse Reactions In Indian Girls
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - The two human papilloma virus (HPV) vaccines for cervical cancer, Gardasil from Merck & Co and Cervarix from GlaxoSmithKline, continue to be sold in India even as their post-licensing observational study was suspended by local health authorities after reported deaths in the target group